(2-Fluoro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol

Catalog No. :
ACXQCW936
CAS No. :
1417736-84-5
Molecular Formula :
C14H20BFO4
Molecular Weight :
282.12

IUPAC Name:(2-fluoro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol

(2-Fluoro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$728.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-Fluoro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol
IUPAC Name(2-fluoro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol
MDL No.MFCD27756670
Molecular FormulaC14H20BFO4
Molecular Weight282.12
SMILESOCC1=C(OC)C=C(B2OC(C)(C)C(C)(C)O2)C=C1F
InChI KeyKGICEPPTYNGWIJ-UHFFFAOYSA-N
Synonym[2-Fluoro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanol;Benzenemethanol, 2-fluoro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1417736-84-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACXQCW936 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEGNP831 route compound structure diagram
    ACEGNP8312555544-30-2 In Stock
  2. Then
  3. ACXQCW936 route product structure diagram
    ACXQCW9361417736-84-5
Inquiry

2. ACXQCW936 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXQCW936 route product structure diagram
    ACXQCW9361417736-84-5
Inquiry

Comments (0)